UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
 
For the month of, May 2017
Commission File Number 001-37652
 
Midatech Pharma PLC
(Translation of registrant’s name into English)
 
65 Innovation Drive
Milton Park
Abingdon, Oxfordshire, OX14 4RQ, United Kingdom
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
Form 20-F              Form 40-F 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): 
 

 


 
SUBMITTED HEREWITH
 
Attached to the Registrant’s Form 6-K filing for the month of May 2017, and incorporated by reference herein, is:
     
Exhibit No.
  
Description
   
99.1
  
Press release, dated May 19, 2017 entitled “Issue of Equity for Midatech Pharma Share Incentive Plan.”
 


 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
                 
 
 
 
 
Midatech Pharma PLC
       
Date: May 19, 2017
 
 
 
By:
 
/s/ Nicholas Robbins-Cherry
 
 
 
 
 
 
 
 
Nicholas Robbins-Cherry
Chief Financial Officer
 

 
Exhibit Index
 
     
Exhibit No.
  
Description
   
99.1
  
Press release, dated May 19, 2017 entitled “Issue of Equity for Midatech Pharma Share Incentive Plan.”

 
 


Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Midatech Pharma Charts.
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Midatech Pharma Charts.